Report cover image

Biotechnology in the United States

Publisher MarketLine
Published Mar 27, 2025
Length 52 Pages
SKU # MTLN20024327

Description

Biotechnology in the United States

Summary

Biotechnology in the United States industry profile provides top-line qualitative and quantitative summary information including: market share, market size (value 2019-24, and forecast to 2029). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.

Key Highlights
  • Biotechnology market encompasses a broad range of technologies, products, and services that utilize biological systems, organisms, or derivatives to develop or modify processes or products for specific applications. Market value refers to the revenue generated from product sales, licensing fees, royalties, and research funding.
  • The US biotechnology market recorded revenues of $583.1 billion in 2024, representing a compound annual growth rate (CAGR) of 5.4% between 2019 and 2024.
  • The medical/healthcare segment accounted for the market's largest proportion in 2024, with total revenues of $397.1 billion, equivalent to 68.1% of the market's overall value.
  • The US biotechnology market is experiencing unprecedented growth, fueled by a strategic investment in cutting-edge technologies and innovation. For instance, in January 2025, the Department of Commerce granted the Birmingham Biotechnology Hub, led by Southern Research Institute, a $44 million Tech Hubs grant to support Alabama's AI-driven biotechnology.
Scope
  • Save time carrying out entry-level research by identifying the size, growth, major segments, and leading players in the biotechnology market in the United States
  • Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the biotechnology market in the United States
  • Leading company profiles reveal details of key biotechnology market players’ global operations and financial performance
  • Add weight to presentations and pitches by understanding the future growth prospects of the United States biotechnology market with five year forecasts
Reasons to Buy
  • What was the size of the United States biotechnology market by value in 2024?
  • What will be the size of the United States biotechnology market in 2029?
  • What factors are affecting the strength of competition in the United States biotechnology market?
  • How has the market performed over the last five years?
  • Who are the top competitors in the United States's biotechnology market?

Table of Contents

52 Pages
1 Executive Summary
1.1. Market value
1.2. Market value forecast
1.3. Category segmentation
1.4. Geography segmentation
1.5. Market rivalry
1.6. Competitive landscape
2 Market Overview
2.1. Market definition
2.2. Market analysis
3 Market Data
3.1. Market value
4 Market Segmentation
4.1. Category segmentation
4.2. Geography segmentation
5 Market Outlook
5.1. Market value forecast
6 Five Forces Analysis
6.1. Summary
6.2. Buyer power
6.3. Supplier power
6.4. New entrants
6.5. Threat of substitutes
6.6. Degree of rivalry
7 Competitive Landscape
7.1. Who are the key players?
7.2. What strategies do the key players follow?
7.3. What have been the most recent market developments?
8 Company Profiles
8.1. Merck & Co Inc
8.2. AbbVie Inc
8.3. Amgen Inc
8.4. Johnson & Johnson
8.5. Biogen Inc
9 Macroeconomic Indicators
9.1. Country data
10 Appendix
10.1. Methodology
10.2. Industry associations
10.3. Related MarketLine research
10.4. About MarketLine
List of Tables
Table 1: United States biotechnology industry value: $ million, 2019-24
Table 2: United States biotechnology industry category segmentation: % share, by value, 2019-24
Table 3: United States biotechnology industry category segmentation: $ million, 2019-24
Table 4: United States biotechnology industry geography segmentation: $ million, 2024
Table 5: United States biotechnology industry value forecast: $ million, 2024-29
Table 6: Merck & Co Inc: Key Facts
Table 7: Merck & Co Inc: Annual Financial Ratios
Table 8: Merck & Co Inc: Key Employees
Table 9: AbbVie Inc: Key Facts
Table 10: AbbVie Inc: Annual Financial Ratios
Table 11: AbbVie Inc: Key Employees
Table 12: AbbVie Inc: Key Employees Continued
Table 13: Amgen Inc: Key Facts
Table 14: Amgen Inc: Annual Financial Ratios
Table 15: Amgen Inc: Key Employees
Table 16: Amgen Inc: Key Employees Continued
Table 17: Johnson & Johnson: Key Facts
Table 18: Johnson & Johnson: Annual Financial Ratios
Table 19: Johnson & Johnson: Key Employees
Table 20: Biogen Inc: Key Facts
Table 21: Biogen Inc: Annual Financial Ratios
Table 22: Biogen Inc: Key Employees
Table 23: United States Size of Population (Million), 2019-24
Table 24: United States Real GDP (Constant 2010 Prices, $ Billion), 2019-24
Table 25: United States GDP (Current Prices, $ Billion), 2019-24
Table 26: United States Inflation, 2019-24
Table 27: United States Consumer Price Index (Absolute), 2019-24
Table 28: United States Exchange Rate, 2019-24
List of Figures
Figure 1: United States biotechnology industry value: $ million, 2019-24
Figure 2: United States biotechnology industry category segmentation: $ million, 2019-24
Figure 3: United States biotechnology industry geography segmentation: % share, by value, 2024
Figure 4: United States biotechnology industry value forecast: $ million, 2024-29
Figure 5: Forces driving competition in the biotechnology industry in the United States, 2024
Figure 6: Drivers of buyer power in the biotechnology industry in the United States, 2024
Figure 7: Drivers of supplier power in the biotechnology industry in the United States, 2024
Figure 8: Factors influencing the likelihood of new entrants in the biotechnology industry in the United States, 2024
Figure 9: Factors influencing the threat of substitutes in the biotechnology industry in the United States, 2024
Figure 10: Drivers of degree of rivalry in the biotechnology industry in the United States, 2024

Search Inside Report

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us